Back to Search

EDWARD BASTYR, MD

MD

Endocrinology, Diabetes & Metabolism Physician

NPI: 1831266154Individual

Specialties, Licenses & Credentials

General Acute Care Hospital

General Acute Care Hospital

Code: 282N00000X

01044193A(IN)
Endocrinology, Diabetes & Metabolism PhysicianPrimary

Internal Medicine — Endocrinology, Diabetes & Metabolism

Code: 207RE0101X

01044193A(IN)

Research & Publications (11)

Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
PMID 16199253·Clin Ther·2005
8-other
Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro.
PMID 11220353·Diabetes Obes Metab·2000
3-trial
Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
PMID 10977012·Diabetes Care·2000
3-trial
Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom.
PMID 18632033·Prim Care Diabetes·2007
8-other
Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
PMID 17623822·Diabetes Care·2007
8-other
Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity.
PMID 17513707·Diabetes Care·2007
8-other
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
PMID 17392551·Diabetes Care·2007
2-rct
Clinical safety of the selective PKC-beta inhibitor, ruboxistaurin.
PMID 17044810·Expert Opin Drug Saf·2006
6-review
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
PMID 16199243·Clin Ther·2005
4-observational
Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.
PMID 16116628·Muscle Nerve·2005
2-rct
The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.
PMID 15929681·Diabetes Technol Ther·2005
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
720 ESKENAZI AVE, UNIVERSITY MEDICAL DIAGNOSTIC ASSOCIATES, INC.
INDIANAPOLIS, IN 46202

Location

Practice Location

720 ESKENAZI AVE, INDIANAPOLIS, IN
(317) 880-5045

Quick Facts

NPI
1831266154
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
11

Are you this provider?

Claim Your Profile